The Latin America, Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 6.7% CAGR during the forecast period (2021-2027).
The demand for STD testing is predicted to increase as a result of recommendations from various regulatory bodies for annual STD screening for sexually active men and women. STD screening services are now widely covered by health-care plans, which would likely boost the worldwide STD testing market's growth. For example, under the Affordable Care Act in the United States, STD screening treatments are covered without cost-sharing. STD prevention and control techniques have been specified by regulatory bodies like the World Health Organization.
The prevalence of STDs or STIs are gaining a high momentum in the African region, which is leading to various health problems and serious complications. When compared to other regions, Sub-Saharan Africa has the highest annual STD cases. Infections with the herpes simplex virus and the human papillomavirus are becoming more common in Sub-Saharan Africa. While there are more than 20 bacteria that cause STDs, they mostly manifest themselves in four syndromes and can thus be treated syndromically. Many government and major healthcare organizations are working together to improve the state of medical services, especially STD treatment across this region.
The Brazil market dominated the LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2.48 billion by 2027. The Argentina market is poised to grow at a CAGR of 7.3% during (2021 - 2027). Additionally, The UAE market would showcase CAGR of 6.4% during (2021 - 2027).
Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Sexually Transmitted Diseases (STD) Testing Market is Predict to reach $120 Billion by 2027, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.
By Disease Type
By Location of Testing
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 